8-97776054-C-G

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3

The NM_018407.6(LAPTM4B):​c.45C>G​(p.Cys15Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000696 in 1,436,064 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000070 ( 0 hom. )

Consequence

LAPTM4B
NM_018407.6 missense

Scores

6
9
3

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.30

Publications

0 publications found
Variant links:
Genes affected
LAPTM4B (HGNC:13646): (lysosomal protein transmembrane 4 beta) Enables ceramide binding activity; enzyme binding activity; and phosphatidylinositol bisphosphate binding activity. Involved in several processes, including negative regulation of macromolecule metabolic process; regulation of lysosomal membrane permeability; and regulation of lysosome organization. Located in several cellular components, including endosome; lysosomal membrane; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.837

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LAPTM4BNM_018407.6 linkc.45C>G p.Cys15Trp missense_variant Exon 1 of 7 ENST00000521545.7 NP_060877.4 Q86VI4-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LAPTM4BENST00000521545.7 linkc.45C>G p.Cys15Trp missense_variant Exon 1 of 7 1 NM_018407.6 ENSP00000428409.1 Q86VI4-2
LAPTM4BENST00000445593.6 linkc.318C>G p.Cys106Trp missense_variant Exon 1 of 7 1 ENSP00000402301.2 Q86VI4-3
LAPTM4BENST00000619747.1 linkc.318C>G p.Cys106Trp missense_variant Exon 1 of 7 1 ENSP00000482533.1 Q86VI4-3
LAPTM4BENST00000517924.5 linkc.45C>G p.Cys15Trp missense_variant Exon 1 of 5 5 ENSP00000429868.2 H0YBN1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00000945
AC:
2
AN:
211554
AF XY:
0.0000170
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000214
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000696
AC:
10
AN:
1436064
Hom.:
0
Cov.:
34
AF XY:
0.00000420
AC XY:
3
AN XY:
714694
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30260
American (AMR)
AF:
0.00
AC:
0
AN:
43352
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25356
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36062
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85158
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
47726
Middle Eastern (MID)
AF:
0.000362
AC:
2
AN:
5528
European-Non Finnish (NFE)
AF:
0.00000544
AC:
6
AN:
1103140
Other (OTH)
AF:
0.0000336
AC:
2
AN:
59482
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000113
ExAC
AF:
0.00000835
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 26, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.318C>G (p.C106W) alteration is located in exon 1 (coding exon 1) of the LAPTM4B gene. This alteration results from a C to G substitution at nucleotide position 318, causing the cysteine (C) at amino acid position 106 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.92
BayesDel_addAF
Uncertain
0.12
D
BayesDel_noAF
Uncertain
-0.030
CADD
Pathogenic
32
DANN
Uncertain
0.99
DEOGEN2
Benign
0.29
.;.;.;T
Eigen
Uncertain
0.40
Eigen_PC
Uncertain
0.37
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Uncertain
0.93
D;.;D;D
M_CAP
Pathogenic
0.39
D
MetaRNN
Pathogenic
0.84
D;D;D;D
MetaSVM
Benign
-0.44
T
PhyloP100
3.3
PrimateAI
Pathogenic
0.90
D
PROVEAN
Pathogenic
-8.7
.;D;D;.
REVEL
Uncertain
0.46
Sift
Uncertain
0.0010
.;D;D;.
Sift4G
Pathogenic
0.0010
D;D;D;D
Vest4
0.92
MVP
0.75
MPC
1.1
ClinPred
1.0
D
GERP RS
4.3
PromoterAI
-0.044
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.91
gMVP
0.97
Mutation Taster
=6/94
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs773392680; hg19: chr8-98788282; API